Embolism during pregnancy: thrombus, air, and amniotic fluid

Slides:



Advertisements
Similar presentations
The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.
Advertisements

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.
Heparin-coated catheters and heparin-induced thrombocytopenia
Late survival in abdominal aortic aneurysm patients: The role of selective myocardial revascularization on the basis of clinical symptoms  Martha M. Reigel,
William B. Schroder, MD, John F. Bealer, MD 
Pay for Performance in Neonatal-Perinatal Medicine—Will the Quality of Health Care Improve in the Neonatal Intensive Care Unit? A Business Model for Improving.
Recurrent thromboembolism in patients with vena cava filters
Pulmonary Embolism Doug Bretzing, pgy 3
Preface Anesthesiology Clinics of North America
Mural aortic thrombi: An important cause of peripheral embolization
Pre-eclampsia: fluids, drugs, and anesthetic management
Endothelins and inflammation: the gastrointestinal system
CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation  Walid Saliba, MD, MPH, Gad Rennert,
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Embolism during pregnancy: thrombus, air, and amniotic fluid
Heparin-induced thrombocytopenia: twenty-nine years later
NPO during labor Anesthesiology Clinics of North America
Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma 
Misconceptions about neuraxial analgesia
Timothy E. Miller, MB ChB, FRCA  Anesthesiology Clinics 
Clinical and Potential Use of Pharmacological Agents to Reduce Radial Artery Spasm in Coronary Artery Surgery  Saina Attaran, MD, Lindsay John, MD, Ahmed.
Mortality on the waiting list for coronary artery bypass grafting: incidence and risk factors  Helena Rexius, MD, Gunnar Brandrup-Wognsen, MD, PhD, Anders.
Preface Anesthesiology Clinics of North America
Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and Course  Konrad Bork, MD, Gabriele Meng, MD, Petra Staubach, MD, Jochen Hardt,
Sugantha Ganapathy, MBBS, DA, FRCA, FFARCS (I), FRCPC 
Bone cement implantation syndrome
Malcolm O. Perry, MD, Richard Kempczinski, MD 
Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin 
Horn Evelyn M. , MD, Barst Robyn J. , MD, Poon Michael , MD  CHEST 
Early follow-up and treatment recommendations for isolated calf deep venous thrombosis  Kuldeep Singh, MD, Danny Yakoub, MD, PhD, Paul Giangola, BS, Michael.
Protecting the brain and spinal cord
Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD 
Timing of surgery for pulmonary embolism: An evolving paradigm
The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer  Jane T. Hickok, MD, MPH, Joseph A. Roscoe,
Heparin-coated catheters and heparin-induced thrombocytopenia
A. Vincelot, N. Nathan, D. Collet, Y. Mehaddi, P. Grandchamp, A. Julia 
Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis  Yuichi Teraki, MD, Misaki Kawabe, MD, Seiichi.
Recurrent thromboembolism in patients with vena cava filters
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Community-acquired pneumonia in adults
Spasmolytic effects of prostaglandin E1 on serotonin-induced bronchoconstriction and pulmonary hypertension in dogs  Y. Hashimoto, K. Hirota, H. Yoshioka,
David A. Lipski, MD, RVT, Alexander D. Shepard, MD, RVT, Bruce D
Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery  P. Yiu, FRCSa, J. Robin, MRCPb, C.W. Pattison,
Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity  Thomas W. Wakefield, M.D., Walter.
George H. Meier, MD, Bauer Sumpio, MD, PhD, Henry R
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
New local anesthetics Anesthesiology Clinics of North America
Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery  Russell C. Lam,
Georg Matheis, MD, Friedhelm Beyersdorf, MD 
Preface Clinics in Laboratory Medicine
James R. Burnett, MB, BS, FRACS, Robert J. Lusby, MD, FRCS, FRACS 
Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulation  Thomas W. Wakefield, MD, Ignacio Ucros,
Systemic Inflammation, COPD, and Pulmonary Hypertension
Use of Endobronchial Ultrasound for Bedside Diagnosis of Acute Pulmonary Embolism in a Critically Ill Patient  Colleen L. Channick, MD, FCCP, Richard.
Editorial II: Solid as a ROC
Abdominal aortic aneurysm: Results of a family study
High-fidelity patient simulation: validation of performance checklists
Peripheral arterial embolization: Doppler ultrasound scan diagnosis
Max B. Mitchell, MD, David N. Campbell, MD 
Should patient age be a consideration in carotid endarterectomy?
Monitoring vascular surgical performance
Glenn C. Hunter, M.D., Stan N. Carson, M.D. 
Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery†  L. Tritapepe, V. De Santis, D. Vitale, F. Guarracino,
Presidential address: The second-generation vascular surgeon
Embolic lesions from the subclavian artery causing transient vertebrobasilar insufficiency  John J. Ricotta, M.D., Kenneth Ouriel, M.D., Richard M. Green,
Determinants of successful peroneal artery bypass
Nausea and Vomiting Remain a Significant Clinical Problem
Cornelius A. Sullivan, MD, Michael J. Rohrer, MD, Bruce S. Cutler, MD 
Vivienne J. Halpern, MD, Roxana G. Kline, MD, Anthony J
Presentation transcript:

Embolism during pregnancy: thrombus, air, and amniotic fluid Alfredo F Gei, MD, Rakesh B Vadhera, MD, FRCA, FFARCS, Gary D.V Hankins, MD  Anesthesiology Clinics of North America  Volume 21, Issue 1, Pages 165-182 (March 2003) DOI: 10.1016/S0889-8537(02)00052-4

Fig. 1 Components of amniotic fluid and their role in pathophysiology of AFE. Surfactant enhances production of leukotrienes C4 and D4. Endothelin and Prostaglandins E2 and F2α cause coronary vasoconstriction and negative inotropic effect. Leukotrienes induce hypertension followed by hypotension, pronounced negative inotropic effects and bronchoconstriction. IL-1 and TNF-α induce production of endothelin. Thromboxane A2 causes increases in coronary and pulmonary vascular resistance. Collagen and thromboplastin induce platelet activation. Anesthesiology Clinics of North America 2003 21, 165-182DOI: (10.1016/S0889-8537(02)00052-4)

Fig. 2 Chronology and incidence of signs and symptoms of AFE. Amniotic fluid embolism seems to have a logarithmic presentation with a decreasing intensity, frequency and mortality as time elapses since the onset of symptoms. The majority of seriously affected patients will die within the first 30 to 60 minutes after the onset of symptoms (Incidence data modified from Morgan M. Amniotic fluid embolism. Anaesthesia 1979;34:20–32). Anesthesiology Clinics of North America 2003 21, 165-182DOI: (10.1016/S0889-8537(02)00052-4)